JFJosé Marcos Vieira de Albuquerque Filho

José Marcos Vieira de Albuquerque Filho

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


José Marcos Vieira de Albuquerque Filho has a total of 22 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Clinical and Genetic Aspects of Childhood-Onset Demyelinating Charcot–Marie–Tooth's Disease in Brazil

    by Roberta Ismael Lacerda Machado, Paulo Victor Sgobbi de Souza, Igor Braga Farias, Bruno de Mattos Lombardi Badia, José Marcos Vieira de Albuquerque Filho, Ricello José Vieira Lima, Wladimir Bocca Vieira de Rezende Pinto, Acary Souza Bulle Oliveira

    Charcot–Marie–Tooth's disease (CMT) represents the most common inherited neuropathy. Most patients are diagnosed during late stages of disease course during adulthood. We performed a review of clinical, neurophysiological, and genetic diagnoses of 32 patients with genetically defined childhood-onset demyelinating CMT under clinical follow-up in a Brazilian Center for Neuromuscular Diseases from January 2015 to December 2019. The current mean age was 33.1 ± 18.3 years (ranging from 7 to 71 years) and mean age at defined genetic diagnosis was 36.1 ± 18.3 years. The mean age at onset was 6.1 ± 4.4 years. The most common initial complaint was bilateral pes cavus. The genetic basis included PMP22 duplication (CMT1A) (n = 18), GJB1 (CMTX1) (n = 5), MPZ (CMT1B) (n = 3), FIG4 (CMT4J) (n = 3), SH3TC2 (CMT4C) (n = 1), PLEKHG5 (CMTRIC) (n = 1), and PRX (CMT4F) (n = 1). Almost all patients (n = 31) presented with moderate or severe compromise in the CMT neuropathy score 2 with the highest values observed in CMT1B. Medical history disclosed obstructive sleep apnea (n = 5), aseptic meningitis (n = 1/MPZ), akinetic-rigid parkinsonism (n = 1/FIG4), and overlapping chronic inflammatory demyelinating polyneuropathy (n = 1/MPZ). Motor conduction block was detected in three individuals (PMP22, FIG4, MPZ). Acute denervation occurred in seven patients. Nonuniform demyelinating patterns were seen in four individuals (two CMT1A, one CMT1B, and one CMTX1). Abnormal cerebral white matter findings were detected in CMT1A and CMTX1, while hypertrophic roots were seen in CMT1A, CMT1B, and CMTX1. Our study emphasizes a relative oligogenic basis in childhood-onset demyelinating CMT and atypical findings may be observed especially in MPZ, PMP22, and GJB1 gene variants.


  • Open Access

    Immunosuppressors and immunomodulators in Neurology - Part I: a guide for management of patients underimmunotherapy

    by Fabiano Ferreira Abrantes, Marianna Pinheiro Moraes de Moraes, José Marcos Vieira de Albuquerque Filho, Jéssica Monique Dias Alencar, Alexandre Bussinger Lopes, Wladimir Bocca Vieira de Rezende Pinto, Paulo Victor Sgobbi de Souza, Enedina Maria Lobato de Oliveira, Acary de Souza Bulle de Oliveira, José Luiz Pedroso, et al.

    For patients with autoimmune diseases, the risks and benefits of immunosuppressive or immunomodulatory treatment are a matter of continual concern. Knowledge of the follow-up routine for each drug is crucial, in order to attain better outcomes and avoid new disease activity or occurrence of adverse effects. To achieve control of autoimmune diseases, immunosuppressive and immunomodulatory drugs act on different pathways of the immune response. Knowledge of the mechanisms of action of these drugs and their recommended doses, adverse reactions and risks of infection and malignancy is essential for safe treatment. Each drug has a specific safety profile, and management should be adapted for different circumstances during the treatment. Primary prophylaxis for opportunistic infections and vaccination are indispensable steps during the treatment plan, given that these prevent potential severe infectious complications. General neurologists frequently prescribe immunosuppressive and immunomodulatory drugs, and awareness of the characteristics of each drug is crucial for treatment success. Implementation of a routine before, during and after use of these drugs avoids treatment-related complications and enables superior disease control.


  • Open Access

    Adult-onset non-5q proximal spinal muscular atrophy: a comprehensive review

    by Wladimir Bocca Vieira de Rezende Pinto, Paulo Victor Sgobbi de Souza, Bruno Mattos Lombardi Badia, Igor Braga Farias, José Marcos Vieira de Albuquerque Filho, Eduardo Augusto Gonçalves, Roberta Ismael Lacerda Machado, Acary Souza Bulle Oliveira

    Background: Adult-onset spinal muscular atrophy (SMA) represents an expanding group of inherited neurodegenerative disorders in clinical practice. Objective: This review aims to synthesize the main clinical, genetic, radiological, biochemical, and neurophysiological aspects related to the classical and recently described forms of proximal SMA. Methods: The authors performed a non-systematic critical review summarizing adult-onset proximal SMA presentations. Results: Previously limited to cases of SMN1-related SMA type 4 (adult form), this group has now more than 15 different clinical conditions that have in common the symmetrical and progressive compromise of lower motor neurons starting in adulthood or elderly stage. New clinical and genetic subtypes of adult-onset proximal SMA have been recognized and are currently target of wide neuroradiological, pathological, and genetic studies. Conclusions: This new complex group of rare disorders typically present with lower motor neuron disease in association with other neurological or systemic signs of impairment, which are relatively specific and typical for each genetic subtype.


  • Open Access

    Neuromuscular choristoma: a rare cause of congenital non-progressive lower limb amyotrophy

    by Roberta Ismael Lacerda Machado, José Marcos Vieira de Alburquerque Filho, Paulo Victor Sgobbi de Souza, Laís Uyeda Aivazoglou, Bruno de Mattos Lombardi Badia, Stéphanie Yuri Torres Ogata, Igor Braga Farias, André Yui Aihara, Artur da Rocha Corrêa Fernandes, Wladimir Bocca Vieira de Rezende Pinto, et al.

    NMCs of the sciatic nerves, formerly known as neuromuscular hamartomas, are rare tumors with mature skeletal muscle and neural elements1,2. Typical imaging features are important for differential diagnosis, especially in cases with congenital long-standing involvement and monomelic amyotrophy, avoiding unnecessary biopsy and the risk of developing aggressive fibromatosis1,2.